Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies
暂无分享,去创建一个
Aki Tsuchiya | John Brazier | Nick Bansback | J. Brazier | A. Tsuchiya | N. Bansback | A. Anis | Aslam Anis
[1] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[2] A. Pickard,et al. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. , 2000, Medical care.
[3] S. Klarenbach,et al. Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin , 2010, Canadian Medical Association Journal.
[4] Paul Kind,et al. How do Zimbabweans value health states? , 2003, Population health metrics.
[5] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[6] A. Kasuya. EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.
[7] G. Bennett,et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial , 2010, Canadian Medical Association Journal.
[8] George W. Torrance,et al. Multi-Attribute Health Status Classification Systems , 1995, PharmacoEconomics.
[9] B. Manns,et al. Economic evaluation of sirolimus-eluting stents , 2005, Canadian Medical Association Journal.
[10] M. Mcmurdo,et al. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial , 2007, Canadian Medical Association Journal.
[11] Aki Tsuchiya,et al. A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach. , 2011, Health economics.
[12] Nan Luo,et al. Valuations of EQ-5D Health States: Are the United States and United Kingdom Different? , 2005, Medical care.
[13] Mark Oppe,et al. EQ-5D value sets : inventory, comparative review, and user guide , 2007 .
[14] K. Schmader,et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study , 2010, Canadian Medical Association Journal.
[15] M. Weinstein,et al. QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] Mark Oppe,et al. Discrete choice modeling for the quantification of health states: the case of the EQ-5D. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[17] C. Gudex,et al. Generation of a Danish TTO value set for EQ-5D health states , 2009, Scandinavian journal of public health.
[18] C. Mcintosh,et al. Eliciting Canadian population preferences for health states using the Classification and Measurement System of Functional Health (CLAMES). , 2007, Chronic diseases in Canada.
[19] J. Brazier,et al. Using a discrete choice experiment to estimate health state utility values. , 2012, Journal of health economics.
[20] R. Brooks. EuroQol: the current state of play. , 1996, Health policy.
[21] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[22] Richard Norman,et al. Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task , 2010, Quality of Life Research.
[23] Joshua A Salomon,et al. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data , 2003, Population health metrics.
[24] W. Brouwer,et al. Lead time TTO: leading to better health state valuations? , 2013, Health economics.
[25] C. Carswell. Measuring and Valuing Health Benefits for Economic Valuation , 2007, PharmacoEconomics.
[26] G W Torrance,et al. A utility maximization model for evaluation of health care programs. , 1972, Health services research.
[27] C. Gudex,et al. Time trade-off user manual: props and self-completion methods , 1994 .
[28] Nandini Dendukuri,et al. Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis , 2007, Canadian Medical Association Journal.
[29] G W Torrance,et al. Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.
[30] L. Lamers. The Transformation of Utilities for Health States Worse Than Death: Consequences for the Estimation of EQ-5D Value Sets , 2007, Medical care.
[31] Willingness of patients to change surgeons for a shorter waiting time for joint arthroplasty , 2008, Canadian Medical Association Journal.
[32] M. Weinstein,et al. Preference-based measures in economic evaluation in health care. , 2000, Annual review of public health.
[33] Paul Kind,et al. Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs. , 2003, Health economics.
[34] Dan Greenberg,et al. Trends in the measurement of health utilities in published cost-utility analyses. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[35] N. Ikegami,et al. Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.
[36] L. Lynd,et al. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy , 2006, Canadian Medical Association Journal.
[37] Esther Seiden,et al. On Orthogonal Arrays , 1966 .
[38] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[39] C. Cameron,et al. Cost-effectiveness of insulin analogues for diabetes mellitus , 2009, Canadian Medical Association Journal.
[40] P. Stalmeier,et al. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. , 2006, Health economics.